atixarso 90 mg filmsko obložene tablete
ticagrelor - filmsko obložena tableta - ticagrelor 90 mg / 1 tableta - ticagrelor
atixarso 90 mg filmsko obložene tablete
ticagrelor - filmsko obložena tableta - ticagrelor 90 mg / 1 tableta - ticagrelor
lusmose 50 mg trde kapsule
sunitinib - kapsula, trda - sunitinib 50 mg / 1 kapsula - sunitinib
tilobrastil 60 mg filmsko obložene tablete
ticagrelor - filmsko obložena tableta - ticagrelor 60 mg / 1 tableta - ticagrelor
tecvayli
janssen-cilag international n.v. - teclistamab - multiple myeloma - antineoplastična sredstva - tecvayli is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.
talvey
janssen-cilag international n.v. - talquetamab - multiple myeloma - antineoplastična sredstva - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.